BMB-101: A Novel Therapeutic for Neuropsychiatric Disorders

Health - Beauty 1 views ID: 271920
Check with seller

Published on 2024/11/21

Description

BMB-101 is an innovative drug under development by Bright Minds Biosciences, designed to selectively target the 5-HT2C serotonin receptor. By activating this receptor, BMB-101 aims to address a range of neuropsychiatric conditions, including depression, anxiety, and other mood disorders. Its precise mechanism offers a potential breakthrough in treating conditions that are often resistant to traditional therapies. With its promising ability to modulate the serotonin system, BMB-101 represents a new frontier in mental health treatment, offering hope for improved efficacy and fewer side effects compared to current options.

Location

M5H 3V9
Toronto
Ontario
Canada
43.70011, -79.4163
Get directions →

Comments

No comments has been added yet
Add comment
Send message
Bright
Bright
85 active listings
Last online 10 hours ago
Registered for 1+ year
M5H 3V9, Toronto, Ontario, Canada
Seller's profile All seller items (85) brightmindsbio.com

Be careful!

Never pay down a deposit in a bank account until you have met the seller, seen signed a purchase agreement.
No serious private advertisers ask for a down payment before you meet.
Receiving an email with an in-scanned ID does not mean that you have identified the sender. You do this on the spot, when you sign a purchase agreement.
Report listing
No phone number Send message
Are you a professional seller? Create an account
Non-logged user
Hello wave
Welcome! Sign in or register